A Case of a 51-Year-Old Woman with VMS and Inadequate Response to MHT

This episode, titled "A Case of a 51-Year-Old Woman with VMS and Inadequate Response to MHT," features panelists examining the clinical approach to a patient presenting with persistent moderate to severe VMS following what appears to be an inadequate response to menopause hormone therapy. Rather than accepting the treatment failure at face value, the experts emphasize the importance of a thorough and sensitive inquiry into the patient's prior therapy — including the type, dose, duration, titration, and reason for discontinuation — to determine whether the failure reflects true treatment resistance or a suboptimal therapeutic trial. They stress that this line of questioning must be handled carefully so the patient does not feel dismissed or unheard.

The experts note that while menopausal hormone therapy reduces hot flashes and night sweats by approximately 75%, it does not achieve full resolution in all patients, and a subset of women will continue to experience bothersome VMS even with hormonal treatment. For these patients, a comprehensive reassessment of the full clinical picture is warranted, including concomitant factors such as anxiety and lifestyle variables that may be contributing to symptom burden. The panel concludes that when hormonal therapy has been exhausted or is insufficient, the most effective path forward is a combination approach — layering non-hormonal treatment options with targeted lifestyle modifications to bring the patient closer to meaningful symptom relief.

In the next episode, "Addressing Cognitive Symptoms and Transitioning from MHT to Non-Hormonal Therapy for VMS," panelists will discuss the significant professional and personal impact of menopause-related cognitive symptoms, the workforce implications of untreated VMS, and the key factors that guide the transition from hormonal to non-hormonal treatment approaches when MHT is insufficient or declined.